Total | Obstructive | Vascular | Suppurative | Fibrosis | Allogeneic | p value | |
---|---|---|---|---|---|---|---|
n = 269 | n = 61 | n = 53 | n = 21 | n = 114 | n = 20 | ||
Age, median (IQR) | 44 (31–51) | 45 (37–49) | 28 (20–38) | 47 (39–50) | 48 (39–55) | 33 (21–47) | < .001 |
Sex, male (%) | 136 (50.6) | 17 (27.9) | 22 (41.5) | 11 (52.4) | 77 (53.5) | 9 (45.0) | 0.017 |
Body mass index (kg/m2), median (IQR) | 19.47 (16.89–23.51) | 18.66 (16.68–21.10) | 19.57 (17.73–23.50) | 18.82 (16.34–20.47) | 21.25 (17.19–25.70) | 15.90 (14.37–17.32) | < .001 |
Blood type, n (%) | 0.1875 | ||||||
A | 103 (38.3) | 30 (49.2) | 18 (33.9) | 5 (23.8) | 44 (38.6) | 6 (30.0) | |
O | 71 (26.4) | 12 (19.7) | 11 (20.8) | 10 (47.6) | 33 (28.9) | 5 (25.0) | |
B | 73 (27.1) | 17 (27.9) | 17 (32.1) | 5 (23.8) | 26 (22.8) | 8 (40.0) | |
AB | 22 (8.2) | 2 (3.3) | 7 (13.2) | 1 (4.7) | 11 (9.6) | 1 (5.0) | |
Pre-transplant condition, n (%) | |||||||
Malignancy | 26 (9.7) | 2 (3.3) | 0 (0.0) | 1 (4.8) | 10 (8.8) | 13 (65.0) | < .001 |
Connective tissue disorders | 47 (17.5) | 2 (3.3) | 5 (9.4) | 2 (9.5) | 35 (30.7) | 3 (15.0) | 0.175 |
Supplemental oxygen | 227 (84.4) | 51 (83.6) | 46 (86.8) | 19 (90.5) | 92 (80.7) | 19 (95.0) | 0.999 |
Pulmonary function, median (IQR) | |||||||
Predicted FVC (%) | 58.0 (40.9–80.8) | 80.7 (58.3–87.7) | 83.2 (71.0–94.9) | 48.3 (37.6–61.7) | 44.5 (30.4–59.7) | 43.4 (29.9–50.6) | < .001 |
6-min walk (m) | 300 (199–375) | 260 (187–343) | 386 (296–376) | 261 (187–338) | 288 (163–372) | 249 (168–345) | < .001 |
Estimated RVP (mmHg) | 38.0 (26.0–59.5) | 32.0 (26.0–42.0) | 89.5 (73.0–118.0) | 38.0 (20.0–61.0) | 34.0 (25.0–47.0) | 27.5 (22.0–39.5) | < .001 |
Laboratory, median (IQR) | |||||||
Hemoglobin (g/dL) | 13.6 (12.1–14.9) | 13.7 (13.0–14.8) | 13.3 (11.8–15.3) | 12.1 (11.6–14.6) | 13.7 (12.4–15.1) | 12.3 (11.1–14.6) | 0.127 |
Albumin (g/dL) | 3.9 (3.6–4.2) | 4.1 (3.9–4.3) | 4.2 (3.8–4.4) | 3.5 (3.2–3.8) | 3.8 (3.5–4.1) | 3.9 (3.6–4.0) | < .001 |
Creatinine (mg/dL) | 0.68 (0.57–0.79) | 0.62 (0.53–0.71) | 0.70 (0.60–0.80) | 0.60 (0.48–0.70) | 0.70 (0.59–0.83) | 0.55 (0.47–0.80) | 0.005 |
Outcomes, n (%) | < .001 | ||||||
Transplanted | 100 (37.2) | 33 (54.1) | 19 (35.8) | 11 (52.4) | 31 (27.2) | 6 (30.0) | |
Dead | 97 (36.1) | 8 (13.1) | 17 (32.1) | 7 (33.3) | 58 (50.9) | 7 (35.0) | |
Waiting (on March 2021) | 72 (26.8) | 20 (32.8) | 17 (32.1) | 3 (14.3) | 25 (21.9) | 7 (35.0) | |
Wait time, median day (IQR) | |||||||
Time to transplant (n = 100) | 796 (579–1056) | 981 (678–1132) | 959 (602–2015) | 758 (676–943) | 730 (331–849) | 730 (331–849) | 0.059 |
Time to death (n = 97) | 323 (129–528) | 599 (176–891) | 465 (201–897) | 196 (5–410) | 315 (113–513) | 287 (132–449) | 0.083 |
Time to events/censoring (n = 269) | 573 (283–991) | 930 (538–1193) | 959 (483–1804) | 685 (203–954) | 445 (16–641) | 403 (240–640) | < .001 |